Figure 5.
In-vitro release of free celecoxib (CLX) and the optimized formulation (CLX-IPP) in the dissolution medium (pH 7.4) containing 1% (w/v) sodium lauryl sulfate for 24 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.